Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

European Journal of Heart Failure
Alessandro BoccanelliAREA IN-CHF Investigators

Abstract

To test whether canrenone, an aldosterone receptor antagonist, improves left ventricular (LV) remodelling in NYHA class II heart failure (HF). Aldosterone receptor antagonists improve outcome in severe HF, but no information is available in NYHA class II. AREA IN-CHF is a randomized, double-blind, placebo-controlled study testing canrenone on top of optimal treatment in NYHA class II HF with low ejection fraction (EF) to assess 12-month changes in LV end-diastolic volume (LVEDV). Brain natriuretic peptide (BNP) was also measured. Information was available for 188 subjects on canrenone and 194 on placebo. Left ventricular end-diastolic volume was similarly reduced (-18%) in both arms, but EF increased more (P = 0.04) in the canrenone (from 40% to 45%) than in the placebo arm (from 40-43%). Brain natriuretic peptide (n = 331) decreased more in the canrenone (-37%) than in the placebo arm (-8%; P < 0.0001), paralleling a significant reduction in left atrial dimensions (-4% vs. 0.2%; P = 0.02). The composite endpoint of cardiac death and hospitalization was significantly lower in the canrenone arm (8% vs. 15%; P = 0.02). Canrenone on top of optimal treatment for HF did not have additional effects on LVEDV, but it increased EF, and ...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jun 1, 1992·Journal of the American College of Cardiology·A GanauJ H Laragh
Sep 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·N B SchillerI Schnittger
Feb 15, 1986·The American Journal of Cardiology·R B DevereuxN Reichek
Jul 1, 1972·Journal of Pharmaceutical Sciences·W SadéeS Riegelman
Mar 1, 1983·Journal of the American College of Cardiology·D W WahrN B Schiller
Dec 1, 1995·European Heart Journal·A D Struthers
May 1, 1996·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·M CecconiA Soro
Aug 9, 2001·European Heart Journal·W J RemmeUNKNOWN Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology
Jul 2, 2002·Cardiovascular Drugs and Therapy·Victor J DzauMichael Weber
Jul 11, 2002·Journal of the American College of Cardiology·Mariantonietta CicoiraPiero Zardini
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Jun 5, 2003·Annals of Internal Medicine·Thomas J WangRamachandran S Vasan
Oct 3, 2003·Journal of the American College of Cardiology·Pamela S Douglas
Jan 30, 2004·Annual Review of Medicine·William H Gaasch, Michael R Zile
Apr 17, 2004·Kidney International·Mark M MitsnefesStephen R Daniels
Aug 18, 2004·Journal of Hypertension·Philippe GosseRoland Schmieder
Dec 21, 2004·Journal of the American College of Cardiology·Marc VanderheydenJozef Bartunek
Mar 3, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·J M SandallJ C McElnay
Jun 20, 2006·Journal of the American College of Cardiology·Walter P AbhayaratnaTeresa S M Tsang
Nov 28, 2006·European Journal of Heart Failure·Colin BerryJohn McMurray
Apr 10, 2007·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Anthony M DartUNKNOWN ACTION investigators

❮ Previous
Next ❯

Citations

Jan 6, 2011·Current Heart Failure Reports·Miriam S Jacob, W H Wilson Tang
Nov 16, 2010·The New England Journal of Medicine·Faiez ZannadUNKNOWN EMPHASIS-HF Study Group
Feb 24, 2010·Circulation·Bradley A Maron, Jane A Leopold
Jul 7, 2011·Vascular Health and Risk Management·Jean M Nappi, Adam Sieg
Jul 10, 2013·Vascular Health and Risk Management·Jason L GuichardMustafa I Ahmed
Jun 3, 2009·Current Heart Failure Reports·Marcelle D SmitDirk J van Veldhuisen
Sep 14, 2014·Heart Failure Clinics·Emilia D'Elia, Henry Krum
Jul 14, 2014·Seminars in Nephrology·Juan TamargoLuis M Ruilope
Aug 23, 2012·Expert Review of Cardiovascular Therapy·Masataka Watanabe, Henry Krum
Apr 22, 2009·Expert Opinion on Drug Metabolism & Toxicology·James A MuldowneyCassandra D Benge
Nov 8, 2013·The American Journal of the Medical Sciences·Enrico VizzardiLivio Dei Cas
Dec 5, 2015·European Journal of Heart Failure·Peter BramlageRoland E Schmieder
Feb 1, 2011·Trends in Cardiovascular Medicine·Daniela Fraccarollo, Johann Bauersachs
Sep 20, 2011·Revista española de cardiología·Esteban López-de-SáUNKNOWN en representación de los investigadores del REICIAM
Sep 24, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G de SimoneUNKNOWN AREA-in-CHF Investigators
Apr 28, 2012·European Journal of Clinical Investigation·Paolo Galuppo, Johann Bauersachs
Nov 3, 2011·Fundamental & Clinical Pharmacology·Finn GustafssonPatrick Rossignol
Sep 24, 2011·European Journal of Heart Failure·Robin A P WeirJohn M C Connell
Oct 23, 2010·European Journal of Heart Failure·John G F ClelandAndrew L Clark
Jun 11, 2015·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Enrico VizzardiMarco Metra
Jun 6, 2015·International Journal of Cardiology·Maurizio Volterrani, Ferdinando Iellamo
Jan 22, 2013·Current Opinion in Pharmacology·Carolin Zwadlo, Johann Bauersachs
Apr 12, 2014·JACC. Heart Failure·Gianluigi SavaresePasquale Perrone-Filardi
Feb 27, 2010·Journal of Cardiovascular Medicine·Filippo BrandimarteMihai Gheorghiade
Dec 3, 2016·BMC Cardiovascular Disorders·Nicolas M Berbenetz, Marko Mrkobrada
Dec 3, 2016·Journal of the American College of Cardiology·Michael R ZileScott D Solomon
Dec 17, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Maya GuglinPravin Pratap
Aug 8, 2009·Therapeutic Advances in Cardiovascular Disease·Moiz M Shafiq, Alan B Miller
Jul 22, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Rosario RossiMaria Grazia Modena
Aug 26, 2017·Circulation·Brian FeingoldUNKNOWN American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Young; Council
May 9, 2012·European Journal of Heart Failure·Gian Francesco MuredduUNKNOWN PREDICTOR Study Group
Mar 30, 2013·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Rosario RossiFabio Sgura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.